Company Filing History:
1 out of 4 
1 out of 1 Years Active: 2022
Title: Ester Badami: Innovator in NK-Mediated Immunotherapy
Introduction
Ester Badami is a prominent inventor based in Palermo, Italy. She has made significant contributions to the field of immunotherapy, particularly through her innovative methods for producing activated natural killer (NK) cells. Her work focuses on advancing treatments for various cancers and viral infections.
Latest Patents
Ester Badami holds a patent for her invention titled "NK-mediated immunotherapy and uses thereof." This patent describes a method for producing activated CD3-CD56+ NK cells, which can be utilized in treating tumors, specifically hepatocellular carcinoma (HCC). The invention also addresses the treatment and prevention of HCV infections and post-liver transplant complications. Additionally, it includes pharmaceutical compositions that incorporate these activated NK cells.
Career Highlights
Throughout her career, Ester has worked with notable organizations that focus on medical research and transplantation. She has been associated with the Fondazione Ri.med and the Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione, also known as Ismett. Her work in these institutions has contributed to advancements in medical therapies and patient care.
Collaborations
Due to space limitations, the collaborations section has been omitted.
Conclusion
Ester Badami's innovative work in NK-mediated immunotherapy showcases her dedication to improving cancer treatment and viral infection management. Her contributions are paving the way for future advancements in the field of immunotherapy.